# Neutrophil-lymphocyte Ratio and Platelet-lymphocyte Ratio as Predictors for Adverse Events in EVAR

> **NCT04254211** · — · COMPLETED · sponsor: **University of Thessaly** · enrollment: 230 (actual)

## Conditions studied

- Inflammation in EVAR

## Interventions

- **OTHER:** NLR

## Key facts

- **NCT ID:** NCT04254211
- **Lead sponsor:** University of Thessaly
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-03-01
- **Primary completion:** 2019-02-01
- **Final completion:** 2019-11-01
- **Target enrollment:** 230 (ACTUAL)
- **Last updated:** 2021-04-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04254211

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04254211, "Neutrophil-lymphocyte Ratio and Platelet-lymphocyte Ratio as Predictors for Adverse Events in EVAR". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT04254211. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*